Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 538.00
Bid: 540.00
Ask: 543.00
Change: 2.00 (0.37%)
Spread: 3.00 (0.556%)
Open: 533.00
High: 549.00
Low: 532.00
Prev. Close: 536.00
POLR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Dalton Strategic Partnership LLP

17 Dec 2020 07:00

RNS Number : 9794I
Polar Capital Holdings PLC
17 December 2020
 

17 December 2020

 

 

Polar Capital Holdings plc

to acquire Dalton Strategic Partnership LLP

 

 

Polar Capital Holdings plc ("Polar Capital"), the specialist active asset management group, today announces it has reached an agreement to acquire 100% of the issued share capital of Dalton Capital (Holdings) Limited, the parent company of Dalton Strategic Partnership LLP ("Dalton"), a UK based boutique asset manager with Assets under Management ("AuM") of £1.24bn as at 15 December 2020, from its shareholders (the "Acquisition" and the "Transaction"). This AuM figure excludes AuM in the Velox Fund which is on the Dalton platform but is not part of this transaction.

 

Dalton is a London based, independent, asset manager with a strong European equity capability and distribution reach. The firm's AuM, excluding the Velox Fund, comprises £1.12bn in the Melchior European Opportunities Fund and related segregated accounts, managed by David Robinson, together with £0.12bn of European long/short funds managed by Leonard Charlton and three smaller Global and Asian funds managed by Nick Mottram.

 

The Melchior European Opportunities Fund has a strong performance record since its inception in 2010 delivering top quartile performance within its Morningstar peer group over the last three and five years, and since inception, as at the end of November 2020.

 

The Acquisition has a strong strategic rationale for Polar Capital with its growth and diversification strategy. It adds a leading European investment team which is complementary to Polar Capital's existing European Income team, with established funds, and a longstanding track record. It also provides Polar Capital with broader wholesale and institutional distribution into Europe, particularly in the German market. The Acquisition includes the existing Luxembourg SICAV umbrella which will aid Polar Capital's product range for international distribution.

 

The total consideration is based on the AuM at exchange and at current AuM will total circa £15.6m split between the initial consideration of £8.3m of which £7.8m will be paid in cash from Polar Capital's existing resources and £0.5m in Polar Capital shares and further deferred cash consideration in the region of £7.3m, payable 12 months after completion, with the amount being linked to the value of AuM at the time. While the deferred consideration will vary up or down with the level of AuM, the maximum deferred consideration payable is circa £13.2m, therefore the maximum payable under the transaction is circa £21.5m

 

The costs of the Transaction are expected to be £6.2m in total and will include £2.6m of termination costs (which will be incurred post completion and have been deducted in arriving at the circa £15.6m consideration) and £3.6m of reorganisation costs. The termination and reorganisation costs will be treated as exceptional items to be incurred in the financial years ending March 2021 and March 2022. Following the completion of the Transaction it is anticipated that the Acquisition will, on an adjusted diluted earnings per share basis, be immediately earnings enhancing.

 

The Acquisition is subject to FCA approval and is expected to complete in Q1 2021 with a transition of the DSP business onto the Polar Capital platform during Q2 2021.

 

Gavin Rochussen, CEO, Polar Capital said:

"The Acquisition of Dalton Strategic Partnership is further delivery of our growth and diversification strategy and is an excellent strategic, geographic and cultural fit with our existing business. It delivers greater scale, new capabilities and an expanded distribution reach in Europe, as well as highly experienced investment teams with a good track record. This acquisition will also provide Polar Capital with its first Luxembourg SICAV.

 

We are confident that the acquisition will be immediately earnings enhancing and look forward to welcoming the DSP team and clients to Polar."

 

 

Nick Mottram, CEO, Dalton said:

" We have long been impressed by Polar Capital's strong client focus, proposition and growth aspirations and are delighted to be joining the Group. It is a good cultural fit for us and that was important when we were looking to join a larger group, as we wanted to ensure we retained investment autonomy over our funds, something that our founding partner, Andrew Dalton, believed in fundamentally when he started the firm back in 2002.

The managers of our two key investment strategies, David Robinson and Leonard Charlton , are committed and enthusiastic about the Acquisition and the opportunity it will provide to further develop their investment propositions to the benefit of their investors.

 

We are confident that this is an excellent strategic fit for Dalton and look forward to growing a strong franchise within Polar Capital."

 

 

 

For further information please contact:

Polar Capital

Gavin Rochussen (Chief Executive)John Mansell (Executive Director)

Samir Ayub (Finance Director)

+44 (0)20 7227 2700

 

Numis Securities Limited - Nomad and Joint Broker

Charles Farquhar

Stephen Westgate

Kevin Cruickshank (QE)

 

+44 (0)20 7260 1000

 

 

Peel Hunt LLP - Joint Broker

Andrew Buchanan

Rishi Shah

 

+44 (0)20 7418 8893

 

Camarco

Ed Gascoigne-Pees

Georgia Edmonds

Monique Perks

 

 

+44 (0)20 3757 4995

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQGLBDDLBBDGGR
Date   Source Headline
26th Apr 202410:33 amRNSForm 8.3 - RENALYTIX PLC
17th Apr 20243:55 pmRNSDirector/PDMR Shareholding
12th Apr 20245:43 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSAuM Update
9th Apr 20244:01 pmRNSChange of Company Secretary
15th Mar 20243:02 pmRNSForm 8.3 - Renalytix PLC
15th Mar 202410:23 amRNSForm 8.3 - Renalytix PLC - Replacement
13th Mar 20246:14 pmRNSForm 8.3 - RENALYTIX PLC
7th Mar 20244:30 pmRNSHolding(s) in Company
6th Mar 20245:47 pmRNSForm 8.3 - DIRECT LINE INSURANCE GROUP PLC
6th Mar 20245:37 pmRNSForm 8.3 - RENALYTIX PLC
27th Feb 20242:19 pmRNSForm 8.3 - Wincanton PLC
7th Feb 20242:09 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBlock listing Interim Review
25th Jan 20244:53 pmRNSForm 8.3 -Wincanton PLC
11th Jan 20247:00 amRNSAuM Update
10th Jan 20242:54 pmRNSHolding(s) in Company
10th Jan 20242:51 pmRNSHolding(s) in Company
20th Nov 20237:00 amRNSPolar Capital Holdings Unaudited interim results
9th Nov 20237:00 amRNSInvestor Presentation covering Interim Results
26th Oct 20237:00 amRNSNotice of Interim Results
12th Oct 20237:00 amRNSAuM Update
28th Sep 20235:36 pmRNSResult of AGM
18th Aug 20234:45 pmRNSDirector/PDMR Shareholding
1st Aug 202312:05 pmRNSBlock listing Interim Review
19th Jul 20234:34 pmRNSDirector/PDMR Shareholding
18th Jul 20234:30 pmRNSDirector/PDMR Shareholding
13th Jul 202311:01 amRNSDirector/PDMR Shareholding - Replacement
13th Jul 202310:48 amRNSDirector/PDMR Shareholding
13th Jul 202310:31 amRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSAuM Update
26th Jun 20233:34 pmRNSInvestor Presentation covering Full Year Results
26th Jun 20237:00 amRNSGroup Audited Results for year ended 31 March 2023
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 202312:26 pmRNSIssue of Equity
10th May 20233:10 pmRNSDirector/PDMR Shareholding
21st Apr 20232:36 pmRNSHolding(s) in Company
14th Apr 20234:01 pmRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSAuM Update
31st Mar 202312:23 pmRNSDirector/PDMR Shareholding
10th Mar 20233:17 pmRNSDirector/PDMR Shareholding
24th Feb 20235:18 pmRNSForm 8.3 - REDX Pharma PLC
16th Feb 20235:06 pmRNSDirector/PDMR Shareholding
7th Feb 202311:09 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSBlock listing Interim Review
12th Jan 20237:00 amRNSAuM Update
30th Dec 20227:00 amRNSDirectorate Change
21st Nov 20227:00 amRNSUnaudited interim results
15th Nov 20227:00 amRNSInvestor Presentation covering Interim Results
24th Oct 20227:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.